Copper peptide

GHK-Cu

GHK joined to copper. It is studied in skin, tissue, and wound-related research.

Open calculator → View research listing ↗External listing at JD BioWorks

Whole vial: 100 mg Vial math ↓

01 / Overview

Why people look it up

GHK-Cu is popular in skin-care and repair discussions because it binds copper and has been studied in skin and wound models.

  • Skin appearanceLIMITED HUMAN EVIDENCE

    A 13-person topical study had mixed results and no objective between-group improvement; it did not study this vial. Read source ↗

  • Wound and tissue repairANIMAL / PRECLINICAL EVIDENCE

    Rat work examined tissue-matrix changes during wound healing. Read source ↗

  • Hair growthINSUFFICIENT EVIDENCE

    Hair claims are often mixed with studies of a different copper peptide, AHK-Cu. Read source ↗

The labels show the evidence for each claim. Open a row for its source.

02 / Amounts & schedules

Dosage at a glance

Publicly reported examples

Dosage source summary

Lower example
1 mg/day
Middle example
2 mg/day
Higher example
4 mg/day
How often
Daily in these selected accounts
Time on / time off
Some describe breaks; others describe continued use without scheduled breaks.
Route
Injection discussions; exact route is not always stated.

Selected examples, not a consensus or safety range. Other amounts also appear in public discussions.

These source amounts do not establish a safe human dose for a research vial.

Sources & individual reports
Source of the amount boxes

Selected examples, not a consensus or safety range. Other amounts also appear in public discussions. Source check: 2026-10-18.

Source coverage: 3 reviewed public accounts. Separate examples, not a representative sample.

Report 1 ↗First-person account

Amount reported
1 mg GHK-Cu each time
How often reported
daily
Reported duration / cycle
about six weeks described; a month break and another round were proposed, not observed
Route (how it was taken)
subcutaneous, as stated by commenter

What the account says: The commenter also used a topical GHK-Cu product, BPC-157, collagen, and hyaluronic acid. Perceived skin changes cannot be attributed to the injected GHK-Cu alone.

Product match & source details

Product match: The injectable research product and topical formulation were not independently verified.

r/Peptides firsthand comment · Posted: date not independently verified · Reviewed: 2026-10-03.

Report 2 ↗First-person account

Amount reported
2 mg GHK-Cu each time
How often reported
daily during the reported cycle
Reported duration / cycle
30 days on, 14 days off; commenter later said they stopped after getting the skin change they wanted
Route (how it was taken)
not stated in the checked comment

What the account says: The commenter also reported taking zinc. The post did not document a controlled skin outcome or verify the product.

Product match & source details

Product match: Exact GHK-Cu formulation and vial were not verified.

r/Peptides firsthand comment · Posted: date not independently verified · Reviewed: 2026-10-03.

Report 3 ↗First-person account

Amount reported
2 mg each time
How often reported
daily
Reported duration / cycle
four weeks on, one week off, repeated over about three months
Route (how it was taken)
subcutaneous, as stated by poster

What the account says: Poster said they had not noticed a result. Other replies in the same thread describe different amounts; this post is not a typical range.

Product match & source details

Product match: The vial and copper-peptide formulation were not verified.

r/Peptidesource firsthand post · Posted: date not independently verified · Reviewed: 2026-10-03.

How much agreement is there? The checked accounts use different routes and formulations. Their amounts must not be pooled into one range.

Public sources last reviewed: 2026-10-03. Product identity and reported results were not independently verified. Source method →

03 / Go deeper

Evidence, sources & vial math

What the research actually showsHuman studies, evidence limits and mechanisms
Published evidence, separate from public reports

What has actually been studied?

How we read studies ↗

A small human trial of topical GHK-Cu after laser resurfacing found no objective improvement in redness, wrinkles, or skin quality between groups, although a patient questionnaire differed. Animal and lab work explores wound biology. Neither route speaks directly to this dry vial.

Evidence limits: Small topical-product studies do not establish outcomes, amount, or safety for an injected research vial. Hair and systemic claims need stronger clinical testing.

Product status: Research-vial listings are not FDA-approved medicines. Approved-use labels on this page refer only to the named finished prescription product.

Human research

Topical copper tripeptide after CO2 laser resurfacing 2006

What was found: No significant objective between-group difference in erythema or wrinkles; patient-rated skin quality differed.

Main limit: Very small study of a topical combination product, not this research vial or injection.

Study setup and amounts
Who
People receiving circumoral laser resurfacing
Number of participants
13
Study design
Randomized skin-care regimen comparison
Route
Topical product
Amount studied
The abstract does not state a comparable mg amount
Frequency
Not extractable from abstract
Duration
12-week follow-up
Outcome measured
Erythema, wrinkles, skin appearance, patient questionnaire
Read the primary study ↗

Study and prescription-product amounts describe those sources. They do not select an amount for an online research vial.

How researchers think it might work

GHK-Cu is a small peptide bound to copper. Researchers have studied it in skin products and tissue models; the form and route matter.

Show scientific explanation

A small randomized topical study tested GHK-Cu-containing skin products after laser resurfacing. It did not test injection of a dry research vial. Read supporting source ↗

Vial & syringe mathTurn the vial total and liquid volume into concentration and syringe units
Make sense of the vial

Vial & syringe math

Change the vial total and final liquid volume to see what each U-100 syringe mark represents.

The starting 1 mL is a math example. Enter your final mixed volume to update the numbers.

Concentration (mg per mL)—
In 1 U-100 syringe unit—
In 10 U-100 syringe units—

100 U-100 syringe units = 1 mL. These results assume the labeled amount is evenly mixed through the final liquid volume.

Continue in the calculator →
About this listingResearch-use-only status, seller names and additional background

A research material is not intended for human use. Its name or lab report does not establish suitability for a person. What research use only means →

Compiled by PeptideWhy · Scientific sources last checked 2026-10-03 · Editorial policy · Corrections